Dr Brentjens talks to ecancertv at TAT 2015 about chimeric antigen receptor (CAR) T cell therapy, outlining how it has been used with great success to treat patients with B-cell cancers.
He also discusses some of the practicalities and challenges of using this approach in clinical practice.